StonvexLoading…
StonvexStonvexStonvexCore line items from DWSN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $36.70M | $75.63M | $48.67M | $25.93M |
Operating Income | $8.14M | $-1.66M | $-2.51M | $-1.34M |
Net Income | $7.66M | $-1.94M | $-2.51M | $-2.35M |
EPS (Diluted) | $0.25 | $-0.06 | $-0.08 | $-0.04 |
Total Assets | $64.40M | $56.01M | $40.58M | $45.68M |
Total Liabilities | $41.07M | $40.20M | Not available | Not available |
Cash & Equivalents | $1.37M | $4.91M | $5.08M | $16.23M |
Free Cash Flow OCF − CapEx | $-1.90M | $7.15M | $5.77M | $15.94M |
Shares Outstanding | 31.05M | 31.05M | 31.05M | 31.05M |